Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
10 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
LABORATORIUM M. NUYTINCK from Evergem, company number BE0427563924, closed financial year 2025 with a result of € 705,299 after tax. For that financial year LABORATORIUM M. NUYTINCK recorded revenue of € 24.5 million and equity of € 9.2 million. Compared with financial year 2024, the result moved from € -369,408 to € 705,299. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.
€ 9.2 million
▲ 8% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 705,299
▲ still € 369,408 loss in 2024
Profit after tax over the fiscal year.
€ 441,410
▼ 83% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 9.1 million.
People and assets in 2025
78.1
▼ 3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 5.6 million
▼ 2% vs 2024
€ 71,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 535,260
▲ 46% vs 2024
Of which on lease € 343,619.
Debts at end 2025
€ 342,375
€ 67,116 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 1.9 million
▼ 6% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 38 days on average.
€ 1.1 million
▲ 16% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 25,622,611 | € 23,871,341 | € 23,747,548 | € 24,453,256 | ▲ 3% |
| Profit after taxes | € 1,658,534 | € 570,033 | € -369,408 | € 705,299 | ▲ € 1.1 million |
| Equity | € 15,777,732 | € 16,347,764 | € 8,478,356 | € 9,183,655 | ▲ 8% |
| Total debts | € 2,875,154 | € 3,174,213 | € 3,063,603 | € 3,438,856 | ▲ 12% |
| Cash | € 9,947,790 | € 2,547,610 | € 2,624,520 | € 441,410 | ▼ 83% |
| Retained profit | € 15,682,454 | € 16,236,985 | € 8,367,577 | € 9,072,876 | ▲ 8% |
| Dividend | € 0 | € 0 | € 7,500,000 | € 0 | ▼ 100% |
| Bank debt | € 0 | € 0 | € 0 | € 342,375 | |
| Balance sheet total | € 18,652,886 | € 19,521,977 | € 11,541,959 | € 12,622,510 | ▲ 9% |
| Employees (FTE) | 78.1 | 79.2 | 81.1 | 78.1 | ▼ 3 |
Key figures of LABORATORIUM M. NUYTINCK, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to LABORATORIUM M. NUYTINCK?
What happened at LABORATORIUM M. NUYTINCK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 705,299. Source: NBB ↗
- Emiel Van Camp became a director. NBB
- Post Verba Verbera NV became a director. NBB
- New establishment in Evergem. KBO
- New establishment in Evergem. KBO
- Start of the company according to the CBE. KBO
In short
From € 1.7 million profit in 2022 to € 705,299 profit in 2025.
Paid € 923,005 in corporate taxes since 2022.
Best year ever: 2022, with € 1.7 million profit.
Paid out € 7.5 million in dividends to the owners in total.
A new publication or filing at LABORATORIUM M. NUYTINCK? We notify you, reason included.
Follow LABORATORIUM M. NUYTINCKDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind LABORATORIUM M. NUYTINCK are Emiel Van Camp and Post Verba Verbera NV. The shares are held by Post Verba Verbera NV (100%) and Margareta Nuytinck Emiel Van Camp - (0%).
Directors
According to the 2025 annual accounts
Emiel Van Camp
Director
Also active at: QUOD BONUM, FELIX FAUSTUMQUE SIT, LABO VOOR KLINISCHE BIOLOGIE, POST VERBA VERBERA, ANABIOTEC, OHMX.bio, ERGO TUA RURA MANEBUNT
since 2018
Director · represented by Margareta Nuytinck
Also active at: LABO VOOR KLINISCHE BIOLOGIE, ANABIOTEC, OHMX.bio, Ziphius, MENTANA DX
since 2016
Shareholders
Margareta Nuytinck Emiel Van Camp -
0%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Noorwegenstraat 4
9940 Evergem
Reibroekstraat 13
9940 Evergem
Active since 1 April 1988
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 10 companies are registered at this address.
All companies at this address →LABO VOOR KLINISCHE BIOLOGIE same network
€ 3.6 million gross margin · 2025
POST VERBA VERBERA same network
€ 4.5 million revenue · 2025
ANABIOTEC same network
€ 9 million gross margin · 2025
Group Nuytinck
OHMX.bio same network
€ 1.7 million gross margin · 2025
+5 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0427.563.924
- VAT number
- BE 0427.563.924
- Registered office
- Noorwegenstraat 4, 9940 Evergem
- Names & denominations
- LABORATORIUM M. NUYTINCK
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 July 1985
- Peppol
- Active · Active since 5 Dec 2025
- Activities · NACE
Activiteiten van medische beeldvorming en medische laboratoria
Medische laboratoria
Activiteiten van medische laboratoria